What Bioverativ Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Duvall Diantha | Chief Accounting Officer | Mar 08 | Disposition to Issuer · D | −2,791 | — | — | 0 |
| Vivaldi Coelho Rogerio | EVP, Chief Global Therapeutics | Mar 08 | Disposition to Issuer · D | −5,758 | — | — | 0 |
| Posner Brian S | Director | Mar 08 | Disposition to Issuer · D | −6,693 | — | — | 0 |
| Denner Alexander J | Director | Mar 08 | Disposition to Issuer · D | −1,165,000 | — | — | 0 |
| Denner Alexander J | Director | Mar 08 | Disposition to Issuer · D | −5,001 | — | — | 0 |
| Protopapas Anna | Director | Mar 08 | Disposition to Issuer · D | −1,056 | — | — | 0 |
| Cox John | Chief Executive Officer | Mar 08 | Disposition to Issuer · D | −185,094 | — | — | 0 |
| Greene John | EVP, CFO and Treasurer | Mar 08 | Disposition to Issuer · D | −5,951 | — | — | 0 |
| Brudnick Richard | EVP, Business Development | Mar 08 | Disposition to Issuer · D | −22,952 | — | — | 0 |
| DiFabio Andrea | EVP, Chief Legal Officer | Mar 08 | Disposition to Issuer · D | −30,600 | — | — | 0 |
| Paglia Louis J | Director | Mar 08 | Disposition to Issuer · D | −3,056 | — | — | 0 |
| Celona Lucia | EVP, HR & Corp Commun. Officer | Mar 08 | Disposition to Issuer · D | −20,396 | — | — | 0 |
| Harris Timothy J.r. | EVP, R & D | Mar 08 | Disposition to Issuer · D | −839 | — | — | 0 |
| Paglia Louis J | Director | Mar 05 | Gift · G | −2,000 | — | — | 3,056 |
| Duvall Diantha | Chief Accounting Officer | Mar 02 | Withheld — tax / exercise cost · F | −105 | $104.73 | −$11K | 2,791 |
| Cox John | Chief Executive Officer | Feb 23 | Withheld — tax / exercise cost · F | −5,794 | $104.74 | −$607K | 185,094 |
| Brudnick Richard | EVP, Business Development | Feb 23 | Withheld — tax / exercise cost · F | −924 | $104.74 | −$96.8K | 22,952 |
| DiFabio Andrea | EVP, Chief Legal Officer | Feb 23 | Withheld — tax / exercise cost · F | −917 | $104.74 | −$96K | 30,411 |
| Celona Lucia | EVP, HR & Corp Commun. Officer | Feb 23 | Withheld — tax / exercise cost · F | −389 | $104.74 | −$40.7K | 20,016 |
| Duvall Diantha | Chief Accounting Officer | Feb 22 | Withheld — tax / exercise cost · F | −168 | $104.30 | −$17.5K | 2,896 |
Loading...